Aspira Pathlab & Diagnostics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

10.29

10.29

10.29

10.29

10.29

Share application money

-

-

-

-

-

Preference share capital

1.21

1.08

-

-

-

Reserves & surplus

-3.01

-5.08

-2.47

-2.43

-6.91

Loan funds

Secured loans

4.93

4.93

5.89

5.79

6.18

Unsecured loans

-

-

-

-

-

Total

13.42

11.22

13.71

13.65

9.57

Uses of funds

Fixed assets

Gross block

17.96

13.90

14.32

16.61

12.32

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

11.43

7.11

6.31

7.03

4.57

Net block

6.53

6.79

8.01

9.57

7.75

Capital work-in-progress

-

-

-

-

-

Investments

0.13

-

-

-

-

Net current assets

Current assets, loans & advances

10.85

7.92

9.33

8.56

4.02

Less : current liabilities & provisions

4.09

3.49

3.63

4.49

2.21

Total net current assets

6.77

4.43

5.70

4.07

1.81

Miscellaneous expenses not written

-

-

-

-

-

Total

13.42

11.22

13.71

13.65

9.57

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

1.12

1.12

-

-

-

Number of equity sharesoutstanding (Lacs)

102.93

102.93

102.93

102.93

102.93